Dr.Reddy’s: Outperforms industry again - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Dr.Reddy’s: Outperforms industry again

Oct 17, 2000

Dr. Reddy’s Laboratories (DRL) announced a 46% growth in the turnover for the second quarter of the current year. (This does not include the numbers for Cheminor Drugs, which is slated to be merged with the company in the current year. The merger ratio has been fixed at 9 shares of Dr. Reddy’s for every 25 shares of Cheminor.) The full results are slated to be announced on October 30th 2000. Of the total turnover of Rs 1,135.7 m, 68% is accounted by finished dosages, 30% by bulk actives and the balance by diagnostics. The first half turnover amounts to Rs 3,039.69 m, which implies a growth of 25%. This is nearly double the industry growth of around 13% in the current year.

We project a turnover of Rs 8,658 m in the current year (which includes the numbers of Cheminor and American Remedies) and an EPS in the range of Rs 35 for the full year FY2001. The current price of Rs 1,380 implies an earning multiple of 39.4 times on the full year earnings. There seems to be no dramatic undervlaution at this stage unless the company were to announce a major R & D breakthrough.

Equitymaster requests your view! Post a comment on "Dr.Reddy’s: Outperforms industry again". Click here!


More Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Oct 22, 2020 03:12 PM


  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks